Epstein-barr virus infection abrogates the stimulatory capacity of B cells to a major histocompatibility complex class-II-restricted proliferative T-cell clone
- 28 February 1995
- journal article
- Published by Elsevier in Human Immunology
- Vol. 42 (2), 137-144
- https://doi.org/10.1016/0198-8859(94)00091-4
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia.The Journal of Experimental Medicine, 1992
- Induction of minor histocompatibility antigen—specific T-helper but not T-cytotoxic response is dependent on the source of antigen-presenting cellHuman Immunology, 1990
- Specific recognition of human leukemic cells by allogeneic T cells: II. Evidence for HLA-D restricted determinants on leukemic cells that are crossreactive with determinants present on unrelated nonleukemic cellsBlood, 1990
- SEROLOGICAL AND MOLECULAR STUDIES OF EPSTEIN-BARR VIRUS INFECTION IN ALLOGENEIC MARROW GRAFT RECIPIENTSTransplantation, 1990
- Graft-versus-leukemia reactions after bone marrow transplantationBlood, 1990
- A mouse monoclonal antibody detecting a DR-related MT2-like specificity: Serology and biochemistryHuman Immunology, 1984
- HLA‐DC antigens can serve as recognition elements for human cytotoxic T lymphocytesEuropean Journal of Immunology, 1984
- Distinct HLA‐DR epitopes and distinct families of HLA‐DR molecules defined by 15 monoclonal antibodies (mAb) either anti‐DR or allo‐anti‐Iak crossreacting with human DR molecule. I. Cross‐inhibition studies of mAb cell surface fixation and differential binding of mAb to detergent‐solubilized HLA molecules immobilized to a solid phase by a first mAbEuropean Journal of Immunology, 1983
- Antileukemic Effect of Chronic Graft-versus-Host DiseaseNew England Journal of Medicine, 1981
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979